BioInvent International AB
STO:BINV
BioInvent International AB
Net Change in Cash
BioInvent International AB
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioInvent International AB
STO:BINV
|
Net Change in Cash
kr175.3m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Biogaia AB
STO:BIOG B
|
Net Change in Cash
-kr320.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Net Change in Cash
kr59.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Net Change in Cash
kr147m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-6%
|
CAGR 10-Years
11%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Net Change in Cash
kr235m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
|
BioArctic AB
STO:BIOA B
|
Net Change in Cash
-kr98.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioInvent International AB
Glance View
BioInvent International AB engages in the research and development of novel and immuno-modulatory antibodies for the treatment of cancer. The company is headquartered in Lund, Skane and currently employs 84 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.
See Also
What is BioInvent International AB's Net Change in Cash?
Net Change in Cash
175.3m
SEK
Based on the financial report for Dec 31, 2024, BioInvent International AB's Net Change in Cash amounts to 175.3m SEK.
What is BioInvent International AB's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
16%
The average annual Net Change in Cash growth rates for BioInvent International AB have been -1% over the past three years , 16% over the past five years .
You don't have any saved screeners yet